Advertisement
Screener

DocGo Inc. (DCGO) Graph

DCGO Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2020-09-30: Net income -$2.06K.

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

DCGO revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.GB$12.99MUS$60.43MRevenue$73.42MOperating expenses$91.35MOperating income-$17.92MOther income, net$123.21KResearch & development$3.45MPre-tax income-$17.94MIncome tax$56.13K

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

DCGO revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Mobile HealthServices Segment$21.42MTransportationServices Segment$52.01MRevenue$73.42MOperating expenses$91.35MOperating income-$17.92MOther income, net$123.21KResearch & development$3.45MPre-tax income-$17.94MIncome tax$56.13K

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 2 month

Period endNet income
2020-09-30-$2.06K

Revenue and expense 3 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$73.42M$3.45M$91.35M$56.13K-$15.82M
2026-03-31$75.55M$3.71M$94.26M$19.28K-$14.76M
2025-12-31$74.94M*$3.77M*$179.52M*$30.73M*-$148.04M*
2025-09-30$70.81M$3.19M$112.79M-$13.51M-$27.77M
2025-06-30$80.42M$2.96M$97.90M-$4.63M-$11.16M
2025-03-31$96.03M$3.64M$110.03M-$3.72M-$9.41M
2024-09-30$138.68M$3.15M$128.55M$4.49M$5.50M
2024-06-30$164.95M$2.37M$154.80M$3.71M$6.53M
2024-03-31$192.09M$2.39M$176.21M$5.12M$11.23M
2023-09-30$186.55M$3.24M$177.84M$4.53M(m)
2023-06-30$125.49M$2.57M$123.91M-$355.05K(m)
2023-03-31$113.00M$1.86M$119.91M-$2.13M-$3.47M
2022-12-31(m)(m)(m)(m)$10.99M*
2022-09-30$104.32M$1.37M$100.12M$401.92K$2.47M
2022-06-30$109.52M$1.15M$102.06M$321.66K$11.76M
2022-03-31$117.89M$1.14M$107.80M$440.18K$10.63M
2021-09-30$85.84M$854.62K$84.32M$604.61K$801.57K
2021-06-30$62.19M$664.88K$61.93M-$1.11K$102.01K
2021-03-31$49.69M$569.35K$51.56M$10.03K-$2.00M

Revenue and expense 5 month

Period endNet income
2020-12-31-$4.22M

Revenue and expense 6 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$148.98M$7.15M$185.61M$75.41K-$30.58M
2025-06-30$176.45M$6.60M$207.93M-$8.35M-$20.56M
2024-06-30$357.04M$4.76M$331.01M$8.83M$17.76M
2023-06-30$238.49M$4.44M$243.82M-$2.48M(m)
2022-06-30$227.41M$2.29M$209.86M$761.84K$21.13M
2021-06-30$111.56M$1.13M$113.17M$8.92K-$1.90M

Revenue and expense 9 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$247.26M$9.79M$320.71M-$21.86M-$48.33M
2024-09-30$495.72M$7.90M$459.56M$13.32M$23.25M
2023-09-30$425.04M$7.67M$421.66M$2.04M(m)
2022-09-30$331.73M$3.66M$309.98M$1.16M$23.59M
2021-09-30$197.39M$1.98M$197.49M$613.53K-$1.10M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$322.20M(m)$13.56M$500.23M$8.87M-$196.37M
2024-12-31$616.56M(m)$11.59M$587.87M$14.39M$13.36M
2023-12-31$624.29M(m)$10.86M$609.23M$6.24M$10.05M
2022-12-31$440.52M$523.95M$5.38M$418.68M-$7.96M$34.58M
2021-12-31$318.72M$451.70M$3.32M$303.36M$615.70K$23.74M
2020-12-31$94.09M(m)$1.19M$108.85M$167.44K-$14.80M

Similar stocks

Stock NameCountryMarket CapPE Ratio
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
Omada Health, Inc. (OMDA)United States$1.207B309.08
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Pennant Group, Inc. (PNTG)United States$1.386B39.84
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
GeneDx Holdings Corp. (WGS)United States$2.638B-19.23
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86